BigHat Biosciences is adding Synaffix’s antibody-drug conjugate (ADC) tech to its wardrobe, pairing the science with its antibody design platform to tailor a next-gen ADC pipeline. | BigHat ...

Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...

Foundational to its approach is its novel, proprietary ADC linker platform that enables conjugation of two or more different payloads to an 'off-the-shelf' antibody at a specific site in one step ...

Press Release: Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate ... as well as ease of manufacturing as they advance new technologies for ADC design AU ZH, ...

WASHINGTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- In response to the CHIPS and Science Act of 2022, the U.S. National Science Foundation’s (NSF) National Center for Science and Engineering Statistics ...

Merck invests €70 million to expand ADC manufacturing for novel cancer therapies: Darmstadt, Germany Thursday, October 31, 2024, 09:00 Hrs [IST] Merck, a leading science and tec ...

MilliporeSigma has about 1,700 employees in Wisconsin at facilities in Milwaukee, Port Washington, Sheboygan and in the ...

Following the event, the content will be made available in the Clinical/Scientific Presentation and Publication Highlights section of Sutro Biopharma’s website at AboutSutroBiopharma Sutro Biopharma, ...

An Analog Astronaut plays the role of an astronaut during a simulated ... Gambhir is also pursuing her degree in Computer ...

CMO Dr. Harald Haeske to present innovative approaches for combining ADCs with immune checkpoint inhibitors to enhance therapeutic efficacyOBT will also present insights on its target discovery ...

Discover the Antikythera Mechanism, an ancient Greek marvel that challenges our understanding of historical technology and ...

“Many schools don't have the funding to provide these after school programs, to provide an electronics class or a robotics ...